GALWAY, Ireland--(BUSINESS WIRE)--Vivasure Medical ®, a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced initial positive results from its U.S. IDE ...
GALWAY, Ireland--(BUSINESS WIRE)--Vivasure Medical ®, a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced that it will unveil the results of its U.S ...
CHARLOTTE, N.C., March 27, 2025 /PRNewswire/ -- Vasorum USA, Inc, a privately held, commercial-stage medical device company dedicated to redefining vascular closure, today announced U.S. Food and Drug ...
WAYNE, Pa., May 15, 2019 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care, urology and surgery, coronary and peripheral ...
Abbott Park, IL - The US Food and Drug Administration has approved the StarClose vascular closure system (Abbott), used for femoral-artery closure following diagnostic catheterization procedures, the ...
In the PROTECT AF trial, patients randomized to left atrial appendage closure initially continued taking warfarin and aspirin to promote device endothelialization. At 45 days after the procedure, 86.8 ...
TCT 1413: Paravalvular Leak Following Recurrent Infective Endocarditis of a Mitral Valve Prosthesis: Successful Deployment of Two Amplatzer Vascular Plugs in a Large Defect Receive the the latest news ...
DOI: 10.1016/j.jvir.2025.08.019 The Society of Interventional Radiology (SIR) published new practice guidance for the creation of percutaneous arteriovenous fistulas (pAVFs) for dialysis access. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback